Click for best price
Cancer Stem Cells Market Size, Share 2022
Cancer stem cells (CSCs) are cancer cells (found within tumors or hematological cancers) that possess characteristics associated with normal stem cells, specifically the ability to give rise to all cell types found in a particular cancer sample.
This report contains market size and forecasts of Cancer Stem Cells in Global, including the following market information:
Global top five companies in 2021 (%)
The global Cancer Stem Cells market was valued at 883.8 million in 2021 and is projected to reach US$ 1894 million by 2028, at a CAGR of 11.5% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Cell Culturing Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cancer Stem Cells include Thermo Fisher Scientific, Abbvie, Merck Kgaa, Bionomics, Lonza, Stemline Therapeutics, Miltenyi Biotec, Promocell and Macrogenics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cancer Stem Cells companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cancer Stem Cells Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Cancer Stem Cells Market Segment Percentages, by Type, 2021 (%)
- Cell Culturing
- Cell Separation
- Cell Analysis
- Molecular Analysis
- Others
Global Cancer Stem Cells Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Cancer Stem Cells Market Segment Percentages, by Application, 2021 (%)
- Breast Cancer Diagnosis and Treatment
- Prostate Cancer Diagnosis and Treatment
- Colorectal Cancer Diagnosis and Treatment
- Lung Cancer Diagnosis and Treatment
- Others
Global Cancer Stem Cells Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Cancer Stem Cells Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Cancer Stem Cells revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Cancer Stem Cells revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Thermo Fisher Scientific
- Abbvie
- Merck Kgaa
- Bionomics
- Lonza
- Stemline Therapeutics
- Miltenyi Biotec
- Promocell
- Macrogenics
- Oncomed Pharmaceuticals
- Irvine Scientific
- Stemcell Technologies
- Sino Biological
- Biotime
| Report Attributes |
Report Details |
| Report Title |
Cancer Stem Cells Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
65 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cancer Stem Cells Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer Stem Cells Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer Stem Cells Overall Market Size
2.1 Global Cancer Stem Cells Market Size: 2021 VS 2028
2.2 Global Cancer Stem Cells Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cancer Stem Cells Players in Global Market
3.2 Top Global Cancer Stem Cells Companies Ranked by Revenue
3.3 Global Cancer Stem Cells Revenue by Companies
3.4 Top 3 and Top 5 Cancer Stem Cells Companies in Global Market, by Revenue in 2021
3.5 Global Companies Cancer Stem Cells Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer Stem Cells Players in Global Market
3.6.1 List of Global Tier 1 Cancer Stem Cells Companies
3.6.2 List of Global Tier 2 and Tier 3 Cancer Stem Cells Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Cancer Stem Cells Market Size Markets, 2021 & 2028
4.1.2 Cell Culturing
4.1.3 Cell Separation
4.1.4 Cell Analysis
4.1.5 Molecular Analysis
4.1.6 Others
4.2 By Type - Global Cancer Stem Cells Revenue & Forecasts
4.2.1 By Type - Global Cancer Stem Cells Revenue, 2017-2022
4.2.2 By Type - Global Cancer Stem Cells Revenue, 2023-2028
4.2.3 By Type - Global Cancer Stem Cells Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cancer Stem Cells Market Size, 2021 & 2028
5.1.2 Breast Cancer Diagnosis and Treatment
5.1.3 Prostate Cancer Diagnosis and Treatment
5.1.4 Colorectal Cancer Diagnosis and Treatment
5.1.5 Lung Cancer Diagnosis and Treatment
5.1.6 Others
5.2 By Application - Global Cancer Stem Cells Revenue & Forecasts
5.2.1 By Application - Global Cancer Stem Cells Revenue, 2017-2022
5.2.2 By Application - Global Cancer Stem Cells Revenue, 2023-2028
5.2.3 By Application - Global Cancer Stem Cells Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Cancer Stem Cells Market Size, 2021 & 2028
6.2 By Region - Global Cancer Stem Cells Revenue & Forecasts
6.2.1 By Region - Global Cancer Stem Cells Revenue, 2017-2022
6.2.2 By Region - Global Cancer Stem Cells Revenue, 2023-2028
6.2.3 By Region - Global Cancer Stem Cells Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Cancer Stem Cells Revenue, 2017-2028
6.3.2 US Cancer Stem Cells Market Size, 2017-2028
6.3.3 Canada Cancer Stem Cells Market Size, 2017-2028
6.3.4 Mexico Cancer Stem Cells Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Cancer Stem Cells Revenue, 2017-2028
6.4.2 Germany Cancer Stem Cells Market Size, 2017-2028
6.4.3 France Cancer Stem Cells Market Size, 2017-2028
6.4.4 U.K. Cancer Stem Cells Market Size, 2017-2028
6.4.5 Italy Cancer Stem Cells Market Size, 2017-2028
6.4.6 Russia Cancer Stem Cells Market Size, 2017-2028
6.4.7 Nordic Countries Cancer Stem Cells Market Size, 2017-2028
6.4.8 Benelux Cancer Stem Cells Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Cancer Stem Cells Revenue, 2017-2028
6.5.2 China Cancer Stem Cells Market Size, 2017-2028
6.5.3 Japan Cancer Stem Cells Market Size, 2017-2028
6.5.4 South Korea Cancer Stem Cells Market Size, 2017-2028
6.5.5 Southeast Asia Cancer Stem Cells Market Size, 2017-2028
6.5.6 India Cancer Stem Cells Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Cancer Stem Cells Revenue, 2017-2028
6.6.2 Brazil Cancer Stem Cells Market Size, 2017-2028
6.6.3 Argentina Cancer Stem Cells Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cancer Stem Cells Revenue, 2017-2028
6.7.2 Turkey Cancer Stem Cells Market Size, 2017-2028
6.7.3 Israel Cancer Stem Cells Market Size, 2017-2028
6.7.4 Saudi Arabia Cancer Stem Cells Market Size, 2017-2028
6.7.5 UAE Cancer Stem Cells Market Size, 2017-2028
7 Players Profiles
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Corporate Summary
7.1.2 Thermo Fisher Scientific Business Overview
7.1.3 Thermo Fisher Scientific Cancer Stem Cells Major Product Offerings
7.1.4 Thermo Fisher Scientific Cancer Stem Cells Revenue in Global Market (2017-2022)
7.1.5 Thermo Fisher Scientific Key News
7.2 Abbvie
7.2.1 Abbvie Corporate Summary
7.2.2 Abbvie Business Overview
7.2.3 Abbvie Cancer Stem Cells Major Product Offerings
7.2.4 Abbvie Cancer Stem Cells Revenue in Global Market (2017-2022)
7.2.5 Abbvie Key News
7.3 Merck Kgaa
7.3.1 Merck Kgaa Corporate Summary
7.3.2 Merck Kgaa Business Overview
7.3.3 Merck Kgaa Cancer Stem Cells Major Product Offerings
7.3.4 Merck Kgaa Cancer Stem Cells Revenue in Global Market (2017-2022)
7.3.5 Merck Kgaa Key News
7.4 Bionomics
7.4.1 Bionomics Corporate Summary
7.4.2 Bionomics Business Overview
7.4.3 Bionomics Cancer Stem Cells Major Product Offerings
7.4.4 Bionomics Cancer Stem Cells Revenue in Global Market (2017-2022)
7.4.5 Bionomics Key News
7.5 Lonza
7.5.1 Lonza Corporate Summary
7.5.2 Lonza Business Overview
7.5.3 Lonza Cancer Stem Cells Major Product Offerings
7.5.4 Lonza Cancer Stem Cells Revenue in Global Market (2017-2022)
7.5.5 Lonza Key News
7.6 Stemline Therapeutics
7.6.1 Stemline Therapeutics Corporate Summary
7.6.2 Stemline Therapeutics Business Overview
7.6.3 Stemline Therapeutics Cancer Stem Cells Major Product Offerings
7.6.4 Stemline Therapeutics Cancer Stem Cells Revenue in Global Market (2017-2022)
7.6.5 Stemline Therapeutics Key News
7.7 Miltenyi Biotec
7.7.1 Miltenyi Biotec Corporate Summary
7.7.2 Miltenyi Biotec Business Overview
7.7.3 Miltenyi Biotec Cancer Stem Cells Major Product Offerings
7.7.4 Miltenyi Biotec Cancer Stem Cells Revenue in Global Market (2017-2022)
7.7.5 Miltenyi Biotec Key News
7.8 Promocell
7.8.1 Promocell Corporate Summary
7.8.2 Promocell Business Overview
7.8.3 Promocell Cancer Stem Cells Major Product Offerings
7.8.4 Promocell Cancer Stem Cells Revenue in Global Market (2017-2022)
7.8.5 Promocell Key News
7.9 Macrogenics
7.9.1 Macrogenics Corporate Summary
7.9.2 Macrogenics Business Overview
7.9.3 Macrogenics Cancer Stem Cells Major Product Offerings
7.9.4 Macrogenics Cancer Stem Cells Revenue in Global Market (2017-2022)
7.9.5 Macrogenics Key News
7.10 Oncomed Pharmaceuticals
7.10.1 Oncomed Pharmaceuticals Corporate Summary
7.10.2 Oncomed Pharmaceuticals Business Overview
7.10.3 Oncomed Pharmaceuticals Cancer Stem Cells Major Product Offerings
7.10.4 Oncomed Pharmaceuticals Cancer Stem Cells Revenue in Global Market (2017-2022)
7.10.5 Oncomed Pharmaceuticals Key News
7.11 Irvine Scientific
7.11.1 Irvine Scientific Corporate Summary
7.11.2 Irvine Scientific Business Overview
7.11.3 Irvine Scientific Cancer Stem Cells Major Product Offerings
7.11.4 Irvine Scientific Cancer Stem Cells Revenue in Global Market (2017-2022)
7.11.5 Irvine Scientific Key News
7.12 Stemcell Technologies
7.12.1 Stemcell Technologies Corporate Summary
7.12.2 Stemcell Technologies Business Overview
7.12.3 Stemcell Technologies Cancer Stem Cells Major Product Offerings
7.12.4 Stemcell Technologies Cancer Stem Cells Revenue in Global Market (2017-2022)
7.12.5 Stemcell Technologies Key News
7.13 Sino Biological
7.13.1 Sino Biological Corporate Summary
7.13.2 Sino Biological Business Overview
7.13.3 Sino Biological Cancer Stem Cells Major Product Offerings
7.13.4 Sino Biological Cancer Stem Cells Revenue in Global Market (2017-2022)
7.13.5 Sino Biological Key News
7.14 Biotime
7.14.1 Biotime Corporate Summary
7.14.2 Biotime Business Overview
7.14.3 Biotime Cancer Stem Cells Major Product Offerings
7.14.4 Biotime Cancer Stem Cells Revenue in Global Market (2017-2022)
7.14.5 Biotime Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cancer Stem Cells Market Opportunities & Trends in Global Market
Table 2. Cancer Stem Cells Market Drivers in Global Market
Table 3. Cancer Stem Cells Market Restraints in Global Market
Table 4. Key Players of Cancer Stem Cells in Global Market
Table 5. Top Cancer Stem Cells Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Cancer Stem Cells Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Cancer Stem Cells Revenue Share by Companies, 2017-2022
Table 8. Global Companies Cancer Stem Cells Product Type
Table 9. List of Global Tier 1 Cancer Stem Cells Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cancer Stem Cells Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Cancer Stem Cells Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Cancer Stem Cells Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Cancer Stem Cells Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Cancer Stem Cells Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Cancer Stem Cells Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Cancer Stem Cells Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Cancer Stem Cells Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Cancer Stem Cells Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Cancer Stem Cells Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Cancer Stem Cells Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Cancer Stem Cells Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Cancer Stem Cells Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Cancer Stem Cells Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Cancer Stem Cells Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Cancer Stem Cells Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Cancer Stem Cells Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Cancer Stem Cells Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Cancer Stem Cells Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Cancer Stem Cells Revenue, (US$, Mn), 2023-2028
Table 30. Thermo Fisher Scientific Corporate Summary
Table 31. Thermo Fisher Scientific Cancer Stem Cells Product Offerings
Table 32. Thermo Fisher Scientific Cancer Stem Cells Revenue (US$, Mn), (2017-2022)
Table 33. Abbvie Corporate Summary
Table 34. Abbvie Cancer Stem Cells Product Offerings
Table 35. Abbvie Cancer Stem Cells Revenue (US$, Mn), (2017-2022)
Table 36. Merck Kgaa Corporate Summary
Table 37. Merck Kgaa Cancer Stem Cells Product Offerings
Table 38. Merck Kgaa Cancer Stem Cells Revenue (US$, Mn), (2017-2022)
Table 39. Bionomics Corporate Summary
Table 40. Bionomics Cancer Stem Cells Product Offerings
Table 41. Bionomics Cancer Stem Cells Revenue (US$, Mn), (2017-2022)
Table 42. Lonza Corporate Summary
Table 43. Lonza Cancer Stem Cells Product Offerings
Table 44. Lonza Cancer Stem Cells Revenue (US$, Mn), (2017-2022)
Table 45. Stemline Therapeutics Corporate Summary
Table 46. Stemline Therapeutics Cancer Stem Cells Product Offerings
Table 47. Stemline Therapeutics Cancer Stem Cells Revenue (US$, Mn), (2017-2022)
Table 48. Miltenyi Biotec Corporate Summary
Table 49. Miltenyi Biotec Cancer Stem Cells Product Offerings
Table 50. Miltenyi Biotec Cancer Stem Cells Revenue (US$, Mn), (2017-2022)
Table 51. Promocell Corporate Summary
Table 52. Promocell Cancer Stem Cells Product Offerings
Table 53. Promocell Cancer Stem Cells Revenue (US$, Mn), (2017-2022)
Table 54. Macrogenics Corporate Summary
Table 55. Macrogenics Cancer Stem Cells Product Offerings
Table 56. Macrogenics Cancer Stem Cells Revenue (US$, Mn), (2017-2022)
Table 57. Oncomed Pharmaceuticals Corporate Summary
Table 58. Oncomed Pharmaceuticals Cancer Stem Cells Product Offerings
Table 59. Oncomed Pharmaceuticals Cancer Stem Cells Revenue (US$, Mn), (2017-2022)
Table 60. Irvine Scientific Corporate Summary
Table 61. Irvine Scientific Cancer Stem Cells Product Offerings
Table 62. Irvine Scientific Cancer Stem Cells Revenue (US$, Mn), (2017-2022)
Table 63. Stemcell Technologies Corporate Summary
Table 64. Stemcell Technologies Cancer Stem Cells Product Offerings
Table 65. Stemcell Technologies Cancer Stem Cells Revenue (US$, Mn), (2017-2022)
Table 66. Sino Biological Corporate Summary
Table 67. Sino Biological Cancer Stem Cells Product Offerings
Table 68. Sino Biological Cancer Stem Cells Revenue (US$, Mn), (2017-2022)
Table 69. Biotime Corporate Summary
Table 70. Biotime Cancer Stem Cells Product Offerings
Table 71. Biotime Cancer Stem Cells Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Cancer Stem Cells Segment by Type in 2021
Figure 2. Cancer Stem Cells Segment by Application in 2021
Figure 3. Global Cancer Stem Cells Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Cancer Stem Cells Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Cancer Stem Cells Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cancer Stem Cells Revenue in 2021
Figure 8. By Type - Global Cancer Stem Cells Revenue Market Share, 2017-2028
Figure 9. By Application - Global Cancer Stem Cells Revenue Market Share, 2017-2028
Figure 10. By Region - Global Cancer Stem Cells Revenue Market Share, 2017-2028
Figure 11. By Country - North America Cancer Stem Cells Revenue Market Share, 2017-2028
Figure 12. US Cancer Stem Cells Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Cancer Stem Cells Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Cancer Stem Cells Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Cancer Stem Cells Revenue Market Share, 2017-2028
Figure 16. Germany Cancer Stem Cells Revenue, (US$, Mn), 2017-2028
Figure 17. France Cancer Stem Cells Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Cancer Stem Cells Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Cancer Stem Cells Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Cancer Stem Cells Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Cancer Stem Cells Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Cancer Stem Cells Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Cancer Stem Cells Revenue Market Share, 2017-2028
Figure 24. China Cancer Stem Cells Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Cancer Stem Cells Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Cancer Stem Cells Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Cancer Stem Cells Revenue, (US$, Mn), 2017-2028
Figure 28. India Cancer Stem Cells Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Cancer Stem Cells Revenue Market Share, 2017-2028
Figure 30. Brazil Cancer Stem Cells Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Cancer Stem Cells Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Cancer Stem Cells Revenue Market Share, 2017-2028
Figure 33. Turkey Cancer Stem Cells Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Cancer Stem Cells Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Cancer Stem Cells Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Cancer Stem Cells Revenue, (US$, Mn), 2017-2028
Figure 37. Thermo Fisher Scientific Cancer Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Abbvie Cancer Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Merck Kgaa Cancer Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Bionomics Cancer Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Lonza Cancer Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Stemline Therapeutics Cancer Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Miltenyi Biotec Cancer Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Promocell Cancer Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Macrogenics Cancer Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Oncomed Pharmaceuticals Cancer Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Irvine Scientific Cancer Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Stemcell Technologies Cancer Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Sino Biological Cancer Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Biotime Cancer Stem Cells Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
